<DOC>
	<DOCNO>NCT00002527</DOCNO>
	<brief_summary>RATIONALE : Chemoprevention therapy use certain drug try prevent development recurrence cancer . The use aspirin may effective way prevent recurrence polyps colorectal cancer . PURPOSE : Randomized phase III trial study effectiveness aspirin treat patient stage I , stage II , stage III colorectal cancer surgically remove .</brief_summary>
	<brief_title>Aspirin Treating Patients With Colorectal Cancer That Has Been Surgically Removed</brief_title>
	<detailed_description>OBJECTIVES : I . Determine whether aspirin administer dose 325 mg/day decrease number size new adenoma patient Dukes ' A/B1/B2/C colorectal cancer undergone curative surgical resection . II . Assess whether dose aspirin increase disease-free survival patient . OUTLINE : Randomized , double-blind study . Arm I : Chemoprevention . Enteric-coated Aspirin , ASA , NSC-27223 . Arm II : Control . Placebo , PLCB .</detailed_description>
	<mesh_term>Colorectal Neoplasms</mesh_term>
	<mesh_term>Aspirin</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Histologically document colorectal cancer curatively resect , include : Dukes ' A/B1 ( T12 , N0 , M0 ) Dukes ' B2/C ( T3 , N0 , M0 T , N1 , M0 ) diseasefree 5 year postresection Colonoscopy cecum ( small bowel anastomosis ) removal polyp require within 4 month entry Preparation must adequate visualize mucosa discern presence polyps No familial polyposis ( 100 polyp time resection ) No history inflammatory bowel disease include ulcerative colitis Crohn 's disease PATIENT CHARACTERISTICS : Age : 30 75 Performance status : Physician 's assessment good general health require Life expectancy : At least 5 year Hematopoietic : Not specify Hepatic : Not specify Renal : Not specify Cardiovascular : No NYHA class III/IV status No history angina No history MI No history stroke TIAs No peripheral vascular disease No bleeding diathesis include hemorrhagic stroke No prophylactic aspirin cardiovascular disease Other : No documented peptic ulcer disease within past 15 year No aspirin sensitivity include : Aspirininduced asthma Bronchial hyperreactivity Urticaria Angioedema No requirement sodium warfarin anticoagulant No frequent ( great 36 times/year ) NSAID use within past 5 year No recurrent arthritis musculoskeletal problem No narcotic alcohol dependency ( unless least 6month period abstinence ) No prior concurrent malignancy within 5 year ( include metastasis ) except nonmelanomatous skin cancer No pregnant nursing woman Effective contraception require fertile woman PRIOR CONCURRENT THERAPY : No concurrent enrollment colon cancer treatment trial chemoprevention trial Biologic therapy : At least 6 month since immunosuppressive therapy ( i.e. , azathioprine , methotrexate , cyclosporine ) Chemotherapy : Prior chemotherapy allow patient Dukes ' B2/C colorectal cancer No concurrent chemotherapy Endocrine therapy : Prior nonimmunosuppressive steroid treatment allow Radiotherapy : Prior radiotherapy allow patient Dukes ' B2/C colorectal cancer No concurrent radiotherapy Surgery : Curative resection require</criteria>
	<gender>All</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>74 Years</maximum_age>
	<verification_date>July 2016</verification_date>
	<keyword>colon cancer</keyword>
	<keyword>rectal cancer</keyword>
</DOC>